Metraipolis › archive › dc_2996adbb3abc
Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer — Europe PMC PMID:41537166
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41537166
- DOI
- 10.1016/j.ctro.2025.101098
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T14:21:44.720Z
- SHA-256 of the archived text
4bd762acaa818f88043460d3a257763e82d580d06c6a0ebc269b3b77f716425c- Stable URL of this page
https://metraipolis.com/documento/dc_2996adbb3abc
How to cite
Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer — Europe PMC PMID:41537166 — Europe PMC (en), https://europepmc.org/article/MED/41537166 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2996adbb3abc (Metraipolis archive dc_2996adbb3abc, sha256 4bd762acaa818f88043460d3a257763e82d580d06c6a0ebc269b3b77f716425c)
BibTeX
@misc{dc2996adbb3abc,
title = {Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer — Europe PMC PMID:41537166},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41537166},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2996adbb3abc; sha256 4bd762acaa818f88043460d3a257763e82d580d06c6a0ebc269b3b77f716425c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41537166. Agents can read the archived copy with the MCP tool read_document.